Increased SPON2 gene and protein expression has been observed in liver cancer [10, 11], gastric cancer [12], ovarian cancer [13, 14], pancreatic cancer [15], breast cancer [16], Barrett's adenocarcinoma [17] and prostate cancer [18-23]. Here, SPON2 is linked to prostate carcinoma.